Публикации и Гранты\Группа Химической Биологии - Казанский (Приволжский) федеральный университет
Публикации и Гранты


18. Article. Quartile Q1. Impact Factor = 4.848
Vitaly Chasov, Regina Mirgayazova, Ekaterina Zmievskaya, Raniya Khadiullina, Aygul Valiullina, Joseph Stephenson Clarke,  Albert Rizvanov,  Matthias G. Baud* and  Emil Bulatov* /
Key Players In The Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy //
Front. Oncol., (2020), 10:1460
https://doi.org/10.3389/fonc.2020.01460


17. Article. Quartile Q1. Impact Factor = 3.331
Mirgayazova, R., Khadiullina,R., Chasov, V., Mingaleeva,R., Miftakhova, R., Rizvanov, A., Bulatov, E*. / Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option? // Genes, 2020, 11(6), p.704.
https://doi.org/10.3390/genes11060704


16. Статья.
Д.В. Зайцев, Е.К. Зайкова, А.С. Головкин, Э.Р. Булатов, А.Х. Валиуллина, Р.М. Миргаязова, А.А. Дакс, А.Ю. Зарицкий, А.В. Петухов. / Гранулоцитарно-макрофагальный колониестимулирующий фактор и технология CAR-T при солидных опухолях в эксперименте.
Клиническая онкогематология. 2020;13(2):115–22
http://bloodjournal.ru/granulotsitarno-makrofagalnyj-koloniestimuliruyushhij-faktor-i-tehnologiya-car-t-pri-solidnyh-opuholyah-v-eksperimente/


15. Article. Quartile Q1. Impact Factor = 6.162
Aleksei Titov, Aygul Valiullina, Ekaterina Zmievskaya, Ekaterina Zaykova, Alexey Petukhov, Regina Miftakhova, Emil Bulatov* and Albert Rizvanov / Advancing CAR T-cell therapy for solid tumors: lessons learned from lymphoma treatment // Cancers, 2020, 12, 125.
https://doi.org/10.3390/cancers12010125


14. Article. Quartile Q4. CiteScore = 1.4
Regina Mirgayazova, Raniya Khadiullina, Rimma Mingaleeva, Vitaly Chasov, Marina Gomzikova, Ekaterina Garanina, Albert Rizvanov, Emil Bulatov* / Novel Isatin-based activator of p53 trans­criptional functions in tumor cells // Molecular Biology Research Communications 2019;8(3):119-128 
CiteScore = 1. DOI: 10.22099/mbrc.2019.34179.1419


13. Article. Quartile Q2. Impact Factor = 4.114
Emil Bulatov, Regina Sayarova, Rimma Mingaleeva, Regina Miftakhova, Marina Gomzikova, ​Yuri Ignatyev, Alexey Petukhov, Pavel Davidovich, Albert Rizvanov, Nickolai Barlev / Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors // ​Cell Death Discovery, 4: 103 (2018) https://doi.org/10.1038/s41420-018-0120-z


12. Article. Quartile Q1. Impact Factor = 6.187
Aleksei Titov, Alexey Petukhov, Alena Staliarova, Dmitriy Motorin, Emil Bulatov, Oleg Shuvalov, Surinder M. Soond, Mauro Piacentini, Gerry Melino, Andrey Zaritskey & Nickolai A. Barlev /
The biological basis and clinical symptoms of CAR-T therapy-associated toxicites // 
Cell Death & Disease, 9: 897 (2018) 
https://doi.org/10.1038/s41419-018-0918-x


11. Article. Quartile Q2. Impact Factor = 2.664  
Emil Bulatov, Aygul Valiullina, Regina Sayarova, Albert Rizvanov /
Promising new therapeutic targets for regulation of inflammation and immunity:
RING-type E3 ubiquitin ligases
 //
Immunology Letters (2018) vol. 202, pp. 44-51
https://doi.org/10.1016/j.imlet.2018.08.001



10. Article. Quartile Q1. Impact Factor  = 4.439
Emil Bulatov, Almaz Zagidullin, Aygul Valiullina, Regina Sayarova, Albert Rizvanov /
Small molecule modulators of RING-type E3 ligases: MDM and Cullin families as targets // 
Frontiers in Pharmacology. (2018) 9:450.
https://doi.org/10.3389/fphar.2018.00450



9. Book Chapter
Emil Bulatov. E3 Ubiquitin Ligases as Targets for Small Molecule Drug Discovery: Focusing on the Cullin Ring Family. Chapter in: Ubiquitin Proteasome System: A Review and Directions for Research. (2018) Nova Science Publishers.  
https://novapublishers.com/shop/ubiquitin-proteasome-system-a-review-and-directions-for-research/


8. Article. Quartile Q1. Impact Factor  = 4.439
G. Vafina, E. Zainutdinova, E. Bulatov, M.N. Filimonova /
Endonuclease from Gram-Negative Bacteria Serratia marcescens Is as Effective as Pulmozyme in the Hydrolysis of DNA in Sputum // 
Frontiers in Pharmacology. (2018) Vol. 9. - Is. 114. - PP. 1-8. 
https://doi.org/10.3389/fphar.2018.00114

  


7. Article. Quartile Q3. CiteScore = 2.0
Bulatov, E.
, Khaiboullina, S., dos Reis, H. J., Palotás, A., Venkataraman, K., Vijayalakshmi, M., Rizvanov, A. Ubiquitin-proteasome system: promising protein targets in autoimmune and neurodegenerative diseases
BioNanoScience (Springer International Publishing AG), (2016) 6:341–344. 
dx.doi.org/10.1007/s12668-016-0233-x


6. Article. Quartile Q3. CiteScore = 2.0
Vafina, G., Bulatov, E., Zaynutdinova, E., Filimonova, M. A One-Step Protocol for Chromatographic Purification of Non-recombinant Exogenous Bacterial Enzyme: Nuclease of Serratia marcescens. 
BioNanoScience (Springer International Publishing AG), (2016) 6:335–337. 
dx.doi.org/10.1007/s12668-016-0226-9


5. Article. Quartile Q1. Impact Factor  = 4.238
Bulatov, E.,  Martin, E. M., Chatterjee, S., Knebel, A., Shimamura, S., Konijnenberg, A., Johnson, C., Zinn, N., Grandi, P., Sobott, F., Ciulli, A. Biophysical studies on interactions and assembly of full-size E3 ubiquitin ligase: suppressor of cytokine signaling 2 (SOCS2)-elongin BC-cullin 5-ring box protein 2 (RBX2). 
J. Biol. Chem. 2015, 290, 4178–4191. (IF = 4.573)
dx.doi.org/10.1074/jbc.M114.616664
Cтатья рекомендована F1000Prime в категории Technical Advance

   


4. Article. Quartile Q1. Impact Factor  = 4.220
Bulatov, E.
 and Ciulli, A. Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation
Biochem. J. 2015, 467, 365–386. (IF = 4.396)
dx.doi.org/10.1042/BJ20141450



3. Article. Quartile Q1. Impact Factor  = 2.870
Gadd, M. S., Bulatov, E. and Ciulli, A. Serendipitous SAD Solution for DMSO-Soaked SOCS2-ElonginC-ElonginB Crystals Using Covalently Incorporated Dimethylarsenic: Insights into Substrate Receptor Conformational Flexibility in Cullin RING Ligases. 
PLoS ONE 2015, 10, e0131218. (IF = 3.234)
dx.doi.org/10.1371/journal.pone.0131218


2. Article. Quartile Q1. Impact Factor  = 3.163
Shakhmaeva II, Bulatov ER, Bondar OV, Saifullina DV, Culha M, Rizvanov AA, Abdullin TI. Binding and purification of plasmid DNA using multi-layered carbon nanotubes. Journal of biotechnology. 2011 Mar 20;152(3):102-7.
https://doi.org/10.1016/j.jbiotec.2011.01.022


1. Article. Quartile Q1. Impact Factor  = 4.555
Abdullin TI, Bondar OV, Nikitina II, Bulatov ER, Morozov MV, Hilmutdinov AK, Salakhov MK, Çulha M. Effect of size and protein environment on electrochemical properties of gold nanoparticles on carbon electrodes. Bioelectrochemistry. 2009 Nov 1;77(1):37-42.
https://doi.org/10.1016/j.bioelechem.2009.06.002




ПРИВЛЕЧЕННОЕ ФИНАНСИРОВАНИЕ
(Группа Химической Биологии)


Грант РакФонда "Investigating efficacy mechanisms of T cells with chimeric antigen receptor (CAR-T) against solid tumors". Проект завершен.

РНФ 19-74-20026 "Исследование механизмов эффективности T клеток с химерным антигенным рецептором (CAR-T) против клеточных и животных моделей солидных опухолей" (рук. Ризванов А.А.). Проект продолжается.

РФФИ мол_нр 17-34-50167 "Изучение роли E3-убиквитинлигазы COP1 в активации CD4+ лимфоцитов". Проект завершен.

РФФИ мол_а_дк 16-34-60213 "Исследование воздействия ингибиторов p53-MDM2 на молекулярные и клеточные процессы при рассеянном склерозе". Проект завершен.

РФФИ мол_нр 16-34-50250 "Комплексы оснований Шиффа изатина как потенциальные противоопухолевые препараты". Проект завершен.

СТАРТ-1 917ГС1/17640 "Препарат на основе бактериальной нуклеазы для использования при микробной респираторной инфекции и муковисцидозе". Проект завершен.